AtCor Medical wins new pharmaceutical trial contracts
According to the company, the minimum values of the contracts are $860,000 and $650,000, respectively. These new orders bring the minimum total value of pharmaceutical trial contracts secured
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.